Open an account

Merit Medical Systems

MMSI · NASDAQ

$91.18+$1.22 (+1.36%)TodayMarket closed ·
Prev close $89.96

About MMSI

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 7,500 full-time employees. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. The company also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.

Employees
7,500
Headquarters
South Jordan, Utah
Listed
Sep 16, 1954
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
merit.com

MMSI key statistics

Market cap
5.37B
Price-earnings ratio
37.64
Dividend yield
—
Average volume
611.61K
Volume
688.87K
Open price
$90.86
High today
$91.59
Low today
$90.46
52 Week high
$94.75
52 Week low
$59.74

Merit Medical Systems (MMSI) at a glance

As of Oct 20, 2026, Merit Medical Systems (MMSI) shares are priced at $91.18, giving the company a market cap of 5.37B and a price-to-earnings ratio of 37.64.

Today the stock has traded between $90.46 and $91.59. The current price is 0.8% above the day's low and 0.4% below its high.

Volume so far is 688.87K shares, in line with the average of 611.61K shares a day.

Over the past year Merit Medical Systems has ranged from $59.74 to $94.75, and now sits 90% of the way up that range.

Merit Medical Systems met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $1.19 per share against an estimate of $0.9782.

The average analyst price target is $103.48, 13.5% above the current price, from 8 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

75%of 8 analyst ratings say Buy
  • Buy75.0%
  • Hold25.0%
  • Sell0.0%
Price target · 13 analystsAvg $103.48
Low
$83.83
Now
$91.18
High
$129.15

MMSI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 11.5% on average.

  1. Q3 FY24: reported $0.86 per share against an estimate of $0.8144
  2. Q4 FY24: reported $0.93 per share against an estimate of $0.8455
  3. Q1 FY25: reported $0.86 per share against an estimate of $0.764
  4. Q2 FY25: reported $1.01 per share against an estimate of $0.8675
  5. Q3 FY25: reported $0.92 per share against an estimate of $0.8486
  6. Q4 FY25: reported $1.04 per share against an estimate of $0.9732
  7. Q1 FY26: reported $0.94 per share against an estimate of $0.8493
  8. Q2 FY26: reported $1.19 per share against an estimate of $0.9782

MMSI news

  • Press releasePRNewswire

    Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain

  • Press releasePRNewswire

    PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement

  • Rishabh Mishra

    US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns'

  • Press releaseGlobe Newswire

    Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress

Similar companies

Companies in the same industry as Merit Medical Systems

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.